Young-Jin Kim

Chairman & Chief Executive Officer at Handok, Inc.

Young-Jin Kim

Young-Jin Kim

Chairman & Chief Executive Officer at Handok, Inc.

Biography

Currently, Young-Jin Kim occupies the position of Chairman of Handok, Inc. He is also on the board of Genexine, Inc. and Rezolute, Inc. He received an MBA from Indiana State University and an MBA from Kelley School of Business.

Overview
Career Highlights

Handok, Inc.

RelSci Relationships

80

Number of Boards

3

Birthday

11/1956

Age

62

Relationships
RelSci Relationships are individuals Young-Jin Kim likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Director at Handok, Inc.

Relationship likelihood: Strong

Founder at IMM Private Equity, Inc.

Relationship likelihood: Strong

Founder at Genexine, Inc.

Relationship likelihood: Strong

Former Director & Executive Director at Handok, Inc.

Relationship likelihood: Strong

Professor at Yonsei University

Relationship likelihood: Strong

Professor at Seoul National University

Relationship likelihood: Strong

President at Genexine, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Sanofi Pasteur, Inc.

Relationship likelihood: Strong

Professor at Sung Kyun Kwan University

Relationship likelihood: Strong

Executive Director & Head-Human Resource Education at Handok, Inc.

Relationship likelihood: Strong

Paths to Young-Jin Kim
Potential Connections via
Relationship Science
You
Young-Jin Kim
Chairman & Chief Executive Officer at Handok, Inc.
Education
Class of 1984

Founded in 1920 as the Indiana University School of Commerce and Finance, the Kelley School has grown into one of the most respected business schools in the world. The Kelley School offers undergraduate, MBA, master’s, graduate certificates, and doctoral degrees at IU’s Bloomington and Indianapolis campuses.

Career History
Chairman & Chief Executive Officer
1996 - Current

Handok, Inc. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Medicine, Medical Device, Healthcare Product, Rental, and Gene Analysis. The Medicine business offers ETC and OTC medicines. The Medical Device business offers Barozen, Barozen H, and Sensimed. The Healthcare Product business provides food supplements such as Natureset Q, Freyja, and Friend 'Hutos', medical nutrition, food, and beverage. The Gene Analysis business offers GENECARE, a personal genetic profile analysis. The company was founded on April 27, 1954 and is headquartered in Seoul, South Korea.

Boards & Committees
Non-Executive Director
2015 - Current

Genexine, Inc. engages in research and development of therapeutic vaccines hybrid Fc fusion proteins (hyFc) and DNA (deoxyribonucleic acid) therapeutic vaccines. It operates through the following business divisions: Novel drug development and Cell culture media manufacturing. The company was founded by Young Chul Sung on June 8, 1999 and is headquartered in Seongnam, South Korea.

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations

Young-Jin Kim is affiliated with Handok, Inc., Genexine, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Young-Jin Kim. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Young-Jin Kim's profile does not indicate a business or promotional relationship of any kind between RelSci and Young-Jin Kim.